NCT00980785 Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's Status COMPLETED Phase PHASE4
NCT00976118 Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00975481 A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users Status COMPLETED Phase PHASE1
NCT00973518 Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG) Status COMPLETED Phase N/A
NCT00968097 Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition Status TERMINATED Phase PHASE1
NCT00966017 Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia Status UNKNOWN Phase N/A
NCT00965835 Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome Status UNKNOWN Phase N/A
NCT00965588 Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00959192 Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00955422 Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease Status COMPLETED Phase N/A
NCT00954616 Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly Status COMPLETED Phase N/A
NCT00954538 Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001) Status COMPLETED Phase PHASE1
NCT00954252 Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects Status COMPLETED Phase PHASE1
NCT00951834 Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00950430 Imaging of Brain Amyloid Plaques in the Aging Population Status ENROLLING_BY_INVITATION Phase PHASE4
NCT00948909 Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00948766 Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 Status COMPLETED Phase PHASE4